BIOMAT Database Logo BIOMAT Database Logo

[Medical therapy for cerebral vasospasm]. 2006

Tatsuya Sasaki, and Hiromichi Kasuya, and Ryoji Munakata, and Tsuyoshi Ichikawa, and Namio Kodama
Department of Neurosurgery, Fukushima Medical University.

UI MeSH Term Description Entries
D010208 Papaverine An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels. Cerespan,Papaverine Hydrochloride,Pavabid,Pavatym,Hydrochloride, Papaverine
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator
D020301 Vasospasm, Intracranial Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN). Angiospasm, Intracranial,Cerebral Vasospasm,Intracranial Vasospasm,Cerebral Angiospasm,Cerebral Artery Spasm,Cerebrovascular Spasm,Intracranial Angiospasm,Intracranial Vascular Spasm,Angiospasm, Cerebral,Angiospasms, Cerebral,Angiospasms, Intracranial,Artery Spasm, Cerebral,Artery Spasms, Cerebral,Cerebral Angiospasms,Cerebral Artery Spasms,Cerebral Vasospasms,Cerebrovascular Spasms,Intracranial Angiospasms,Intracranial Vascular Spasms,Intracranial Vasospasms,Spasm, Cerebral Artery,Spasm, Cerebrovascular,Spasm, Intracranial Vascular,Spasms, Cerebral Artery,Spasms, Cerebrovascular,Spasms, Intracranial Vascular,Vascular Spasm, Intracranial,Vascular Spasms, Intracranial,Vasospasm, Cerebral,Vasospasms, Cerebral,Vasospasms, Intracranial

Related Publications

Tatsuya Sasaki, and Hiromichi Kasuya, and Ryoji Munakata, and Tsuyoshi Ichikawa, and Namio Kodama
[Medical treatment for cerebral vasospasm].
November 1993, Nihon rinsho. Japanese journal of clinical medicine,
Tatsuya Sasaki, and Hiromichi Kasuya, and Ryoji Munakata, and Tsuyoshi Ichikawa, and Namio Kodama
Hyperdynamic therapy for cerebral vasospasm.
May 1990, Neurologia medico-chirurgica,
Tatsuya Sasaki, and Hiromichi Kasuya, and Ryoji Munakata, and Tsuyoshi Ichikawa, and Namio Kodama
Antifibrinolytic therapy and cerebral vasospasm.
April 1990, Neurosurgery clinics of North America,
Tatsuya Sasaki, and Hiromichi Kasuya, and Ryoji Munakata, and Tsuyoshi Ichikawa, and Namio Kodama
Intra-arterial vasodilator therapy for parainfectious cerebral vasospasm.
May 2014, Journal of the neurological sciences,
Tatsuya Sasaki, and Hiromichi Kasuya, and Ryoji Munakata, and Tsuyoshi Ichikawa, and Namio Kodama
[Anticoagulant therapy in symptomatic cerebral vasospasm].
December 1986, Neurologia medico-chirurgica,
Tatsuya Sasaki, and Hiromichi Kasuya, and Ryoji Munakata, and Tsuyoshi Ichikawa, and Namio Kodama
[Hypertensive-hypervolemic therapy in cerebral vasospasm].
December 1990, Der Nervenarzt,
Tatsuya Sasaki, and Hiromichi Kasuya, and Ryoji Munakata, and Tsuyoshi Ichikawa, and Namio Kodama
Peri-operative medical management of cerebral vasospasm.
July 2009, Neurological research,
Tatsuya Sasaki, and Hiromichi Kasuya, and Ryoji Munakata, and Tsuyoshi Ichikawa, and Namio Kodama
Intraarterial infusion therapy for cerebral vasospasm: promising but preliminary.
January 2012, World neurosurgery,
Tatsuya Sasaki, and Hiromichi Kasuya, and Ryoji Munakata, and Tsuyoshi Ichikawa, and Namio Kodama
Cardiac performance indices during hypervolemic therapy for cerebral vasospasm.
July 1991, Journal of neurosurgery,
Tatsuya Sasaki, and Hiromichi Kasuya, and Ryoji Munakata, and Tsuyoshi Ichikawa, and Namio Kodama
"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
January 2006, Neurocritical care,
Copied contents to your clipboard!